Class 2 MHRA Medicines Recall: Epilim 500mg Gastro-Resistant Tablets (Sanofi)
Class 2 MHRA Medicines Recall: Epilim 500mg Gastro-Resistant Tablets (Sanofi)
October 14, 2020
Class 2 MHRA Medicines Recall: Epilim 500mg Gastro-Resistant Tablets (Sanofi)
Drug alert number: EL (20) A/48
Date issued: 14 October 2020
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Epilim 500mg Gastro-Resistant Tablets (Sanofi) PL 04425/0303
Sanofi has informed the MHRA that it is recalling the below batches of products as a precautionary measure due to out of specification results for disintegration test during routine stability testing.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| R0601 | 08/2022 | 30 | 6 November 2019 |
| R0602 | 08/2022 | 30 | 5 November 2019 |
| R0603 | 08/2022 | 30 | 6 November 2019 |
Advice for healthcare professionals
Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For stock control enquiries please contact GB-CustomerServices@sanofi.com or phone 0800 854 430
For medical information enquiries please contact uk-medicalinformation@sanofi.com or call 0800 035 25 25
Posted in: Dispensing & Supply, PSNC News, Services & Commissioning
